Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian Bernick

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
Menopause (New York, N.Y.)|May 31, 2021
Evaluation of endometrial progesterone receptor expression after 12 weeks of exposure to a low-dose vaginal estradiol insertSebastian Mirkin, James A Simon, James H Liu, et al.
Menopause (New York, N.Y.)|January 30, 2019
Estradiol and progesterone bioavailability for moderate to severe vasomotor symptom treatment and endometrial protection with the continuous-combined regimen of TX-001HR (oral estradiol and progesterone capsules)Rogerio A Lobo, James Liu, Frank Z Stanczyk, et al.
Maturitas|April 3, 2017
A vaginal estradiol softgel capsule, TX-004HR, has negligible to very low systemic absorption of estradiol: Efficacy and pharmacokinetic data reviewJames A Simon, David F Archer, Ginger D Constantine, et al.
Menopause (New York, N.Y.)|October 28, 2020
TX-001HR is associated with a clinically meaningful effect on severity of moderate to severe vasomotor symptoms in the REPLENISH trialGinger D Constantine, James A Simon, Andrew M Kaunitz, et al.
Contraception|October 20, 2025
Effects of tampon co-usage on the pharmacokinetics of segesterone acetate and ethinyl estradiol released from Annovera vaginal ring systemMarlena G Plagianos, Tracy X Chen, Narender Kumar, et al.
Menopause (New York, N.Y.)|December 7, 2016
The REJOICE trial: a phase 3 randomized, controlled trial evaluating the safety and efficacy of a novel vaginal estradiol soft-gel capsule for symptomatic vulvar and vaginal atrophyGinger D Constantine, James A Simon, James H Pickar, et al.
Obstetrics and Gynecology|June 12, 2018
A 17β-Estradiol-Progesterone Oral Capsule for Vasomotor Symptoms in Postmenopausal Women: A Randomized Controlled TrialRogerio A Lobo, David F Archer, Risa Kagan, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Menopause (New York, N.Y.)|May 31, 2021
Evaluation of endometrial progesterone receptor expression after 12 weeks of exposure to a low-dose vaginal estradiol insertSebastian Mirkin, James A Simon, James H Liu, et al.
Menopause (New York, N.Y.)|January 30, 2019
Estradiol and progesterone bioavailability for moderate to severe vasomotor symptom treatment and endometrial protection with the continuous-combined regimen of TX-001HR (oral estradiol and progesterone capsules)Rogerio A Lobo, James Liu, Frank Z Stanczyk, et al.
Maturitas|April 3, 2017
A vaginal estradiol softgel capsule, TX-004HR, has negligible to very low systemic absorption of estradiol: Efficacy and pharmacokinetic data reviewJames A Simon, David F Archer, Ginger D Constantine, et al.
Menopause (New York, N.Y.)|October 28, 2020
TX-001HR is associated with a clinically meaningful effect on severity of moderate to severe vasomotor symptoms in the REPLENISH trialGinger D Constantine, James A Simon, Andrew M Kaunitz, et al.
Contraception|October 20, 2025
Effects of tampon co-usage on the pharmacokinetics of segesterone acetate and ethinyl estradiol released from Annovera vaginal ring systemMarlena G Plagianos, Tracy X Chen, Narender Kumar, et al.
Menopause (New York, N.Y.)|December 7, 2016
The REJOICE trial: a phase 3 randomized, controlled trial evaluating the safety and efficacy of a novel vaginal estradiol soft-gel capsule for symptomatic vulvar and vaginal atrophyGinger D Constantine, James A Simon, James H Pickar, et al.
Obstetrics and Gynecology|June 12, 2018
A 17β-Estradiol-Progesterone Oral Capsule for Vasomotor Symptoms in Postmenopausal Women: A Randomized Controlled TrialRogerio A Lobo, David F Archer, Risa Kagan, et al.
Pageof 4